During chronic HCV infection NCR dependent NK cytolytic activity directed at HCV is associated with liver inflammation, African American Race, IL28B genotype and response to PegIFN/RBV therapy.

  • Meng Q
  • Rani M
  • Sugalski J
  • et al.
ISSN: 1537-6613
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Abstract

Background. Natural killer (NK)-cells are implicated in the pathogenesis of hepatitis C virus (HCV) infection and outcome of IFN-α based therapy, though mechanisms remain unclear.Methods. To evaluate NK ability to control HCV infection, we analyzed healthy donor and HCV-infected donor NK-cell cytolytic activity directed at HCV-infected target cells.Results. HCV-infected subject natural cytotoxicity receptor (NCR) dependent NK-cell cytolytic activity directed at HCV-infected and uninfected HUH 7.5 target cells was greater than that of cells from healthy donors, and this localized to the African American subset. However, IFN-α-enhanced NK cytolytic function was lower in HCV-infected subjects, again localized mainly to the African American subset. Additionally, while HCV-infected HUH 7.5 cells were more readily targeted than uninfected cells, the selectivity of cytolytic activity for infected targets was lower during HCV infection and after IFN-α stimulation, and lower selectivity was in part attributable to greater NKp46 expression. Furthermore, cytolytic activity was associated with higher serum AST, rs12979860 IL28B genotype, and in vivo response to PegIFN/RBV therapy.Conclusions. These data indicate that during chronic HCV infection, race-associated increase in NCR expression and IL28B-associated cytolytic activity may participate in host response to IFN-α containing HCV therapy.

Cite

CITATION STYLE

APA

Meng, Q., Rani, M. R. S., Sugalski, J. M., Judge, C. J., Phat, S., Rodriguez, B., … Anthony, D. D. (2013). During chronic HCV infection NCR dependent NK cytolytic activity directed at HCV is associated with liver inflammation, African American Race, IL28B genotype and response to PegIFN/RBV therapy. The Journal of Infectious Diseases, 1–28. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24302757

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free